• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Activist Icahn prepares a second board challenge at Illumina -letter

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 19, 2023 at 10:22: AM
via Activist investor Carl Icahn said on Monday that he plans to oust directors at Illumina (ILMN.O), laying the groundwork for a second board challenge at the gene-sequencing company months after shareholders elected one of his director candidates.

article source
 




Top Bottom
Back
Quote